People Focused. Passion Powered. Purpose Driven.

We are dedicated to developing new therapies for Alzheimer’s, Parkinson's, and other neurodegenerative disorders, bringing hope and meaningful change to patients and their families, with compassion guiding our every step.

Alzheimer’s Clinical Trial Info

The Alzheimer’s program at Annovis Bio is dedicated to creating treatments that restore cognitive function by targeting multiple neurotoxic proteins simultaneously.

Learn More

Parkinson's Clinical Trial Info  

The Parkinson's program at Annovis Bio focuses on developing therapies that target neurotoxic proteins, aiming to improve motor function and slow disease progression.

Learn More
Expanded Access Policy

Stay Updated with Annovis Bio, Inc.
(NYSE: ANVS)

Join the Annovis Bio Newsletter to receive the latest updates on our groundbreaking research and developments in neurodegenerative diseases like Alzheimer's and Parkinson's

Helpful Links

Home
About
Our Science
Patient Portal
Investors
Contact Us

ANNOVIS BIO

101 Lindenwood Drive,  Suite 225
Malvern, PA  19355
+1 (484) 875-3192
info@annovisbio.com

CLINICAL TRIALS

clinicaltrials@annovisbio.com

INVESTOR RELATIONS

ir@annovisbio.com
© Annovis Bio, Inc. All Rights Reserved 2024. Licensing